SCHEMBL28291855

SCHEMBL28291855

O=S(=O)(OCC(F)F)c1cccc(O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.41
HSD17B1 P14061 5/20 0.37
HSD17B2 P37059 5/20 0.37
CA2 P00918 2/20 0.36
MMP2 P08253 1/20 0.36
HTR6 P50406 2/20 0.36
ENPP2 Q13822 1/20 0.35
MGLL Q99685 1/20 0.35
CYP3A4 P08684 2/20 0.34
CA12 O43570 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12961258 0.78 CA2 (0.35) CA2CA12CA9PRMT5WDR77
SCHEMBL28291826 0.78 HSD17B1 (0.43) PKMHSD17B1HSD17B2CA2MMP2
SCHEMBL1051160 0.76 PRMT5 (0.60) PKMCA2MMP2CA12ALDH1A1
SCHEMBL27516562 0.75 HSD17B2 (0.42) PKMHSD17B1HSD17B2CA2MMP2
SCHEMBL10985765 0.72 HSD17B2 (0.42) PKMHSD17B1HSD17B2CA2MMP2
Water SCHEMBL28054479 0.70 HSD17B2 (0.41) PKMHSD17B1HSD17B2CA2MMP2
SCHEMBL25279490 0.69 CA1 (0.44) CA2MMP2CA12CA9
SCHEMBL336511 0.69 AGER (0.44) PKMCA2CYP3A4CA12ALDH1A1
SCHEMBL10340796 0.68 CA2 (0.61) PKMHSD17B1HSD17B2CA2HTR6
SCHEMBL31146723 0.68 CA2 (0.61) PKMHSD17B1HSD17B2CA2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-A modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2019-04-02 CN disclosed